New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding

Detalles Bibliográficos
Autores principales: Honore, Patrick M., David, Christina, Attou, Rachid, Redant, Sebastien, Gallerani, Andrea, De Bels, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014763/
https://www.ncbi.nlm.nih.gov/pubmed/32046758
http://dx.doi.org/10.1186/s13054-020-2760-7
_version_ 1783496704337641472
author Honore, Patrick M.
David, Christina
Attou, Rachid
Redant, Sebastien
Gallerani, Andrea
De Bels, David
author_facet Honore, Patrick M.
David, Christina
Attou, Rachid
Redant, Sebastien
Gallerani, Andrea
De Bels, David
author_sort Honore, Patrick M.
collection PubMed
description
format Online
Article
Text
id pubmed-7014763
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70147632020-02-20 New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding Honore, Patrick M. David, Christina Attou, Rachid Redant, Sebastien Gallerani, Andrea De Bels, David Crit Care Letter BioMed Central 2020-02-11 /pmc/articles/PMC7014763/ /pubmed/32046758 http://dx.doi.org/10.1186/s13054-020-2760-7 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Honore, Patrick M.
David, Christina
Attou, Rachid
Redant, Sebastien
Gallerani, Andrea
De Bels, David
New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
title New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
title_full New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
title_fullStr New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
title_full_unstemmed New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
title_short New alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
title_sort new alternative to antidotes for novel oral anticoagulants and ticagrelor in the case of severe bleeding
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014763/
https://www.ncbi.nlm.nih.gov/pubmed/32046758
http://dx.doi.org/10.1186/s13054-020-2760-7
work_keys_str_mv AT honorepatrickm newalternativetoantidotesfornoveloralanticoagulantsandticagrelorinthecaseofseverebleeding
AT davidchristina newalternativetoantidotesfornoveloralanticoagulantsandticagrelorinthecaseofseverebleeding
AT attourachid newalternativetoantidotesfornoveloralanticoagulantsandticagrelorinthecaseofseverebleeding
AT redantsebastien newalternativetoantidotesfornoveloralanticoagulantsandticagrelorinthecaseofseverebleeding
AT galleraniandrea newalternativetoantidotesfornoveloralanticoagulantsandticagrelorinthecaseofseverebleeding
AT debelsdavid newalternativetoantidotesfornoveloralanticoagulantsandticagrelorinthecaseofseverebleeding

Ejemplares similares